Federal Official Gazette
ANS PUBLIC CONSULTATION No. 169, OF MARCH 9, 2026
Art. 1° A Public Consultation is hereby opened, for a period of 20 (twenty) days, from March 11 to March 30, 2026, pursuant to art. 27 of RN No. 555 of 2022, for the submission of criticism and suggestions regarding the preliminary recommendation to incorporate the technologies contained in UAT No. 193 (Olaparib as monotherapy for the treatment of adult patients with metastatic castration-resistant prostate cancer, with mutations in the BRCA1 and/or BRCA2 genes, whose disease has progressed after prior treatment with a new hormonal agent), pursuant to art. 24 of RN No. 555 of 2022.
ANS news
ANS and Ministry of Health promote webinar on combating dengue and chikungunya
The National Supplementary Health Agency (ANS) and the Ministry of Health (MS) will hold, on Mar 17, 2026, from 10:00 a.m. to 12:30 p.m., the webinar “ANS and the Ministry of Health United against Dengue and Chikungunya,” with a live broadcast on ANS’s YouTube channel. The event will be aimed at health plan operators, health service providers and other parties interested in the topic.
Open public consultations
- CP 168. Subject: CP opened for the submission of criticism and suggestions regarding the proposed amendment of Normative Resolutions No. 516 and 521, of 2022. Deadline: Feb 23, 2026 to Apr 9, 2026.
Scheduled public hearings
There are no public hearings scheduled.
Open public calls for input
There is no open public call for input.
Open public calls
No updates.
Other news
– No updates.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.